Sanofi's Euroapi to List in Paris on May 6
01 April 2022 - 5:24PM
Dow Jones News
By Joshua Kirby
Sanofi SA said Friday that its spun-off business Euroapi will
begin trading on May 6 following approval by the French market
regulator.
The French drugmaker will continue to hold around 30% of shares
in the active-pharmaceutical-ingredients business following the
listing, while the French state will acquire a stake of 12% via
sovereign fund EPIC Bpifrance. The remainder will be distributed
via a dividend in kind in addition to the proposed cash dividend
set out last month, Sanofi said, with one Euroapi share given for
every 23 Sanofi shares held.
Euroapi shares will begin trading on the Euronext Paris stock
exchange on May 6, subject to the distribution's approval at a
shareholders' meeting due to be held May 3, Sanofi said. The
company had previously indicated the listing would happen at some
point in the first half of the year.
Sanofi and EPIC Bpifrance will be subject to a lock-up period of
two years on Euroapi shares following the listing, while cosmetics
major L'Oreal SA, Sanofi's largest shareholder, will be subject to
a lock-up of one year.
The reference price for Euroapi shares should be set out after
the close of market on May 5, Sanofi said. Following the
distribution and the stake acquisition by EPIC Bpifrance, Sanofi
will no longer control Euroapi, which should have a slightly
beneficial effect on operating income in 2022, the company
added.
Write to Joshua Kirby at joshua.kirby@wsj.com;
@joshualeokirby
(END) Dow Jones Newswires
April 01, 2022 02:09 ET (06:09 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Euronext NV (EU:ENX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Euronext NV (EU:ENX)
Historical Stock Chart
From Jul 2023 to Jul 2024